STAAR Surgical Net Income 2012-2026 | STAA
STAAR Surgical net income from 2012 to 2026. Net income can be defined as company's net profit or loss after all revenues, income items, and expenses have been accounted for.
|
STAAR Surgical Annual Net Income (Millions of US $) |
|
|---|---|
| 2025 | $-80 |
| 2024 | $-20 |
| 2023 | $21 |
| 2022 | $40 |
| 2021 | $28 |
| 2020 | $6 |
| 2019 | $14 |
| 2018 | $5 |
| 2017 | $-2 |
| 2016 | $-12 |
| 2015 | $-7 |
| 2014 | $-8 |
| 2013 | $0 |
| 2012 | $-2 |
| 2011 | $1 |
|
STAAR Surgical Quarterly Net Income (Millions of US $) |
|
|---|---|
| 2026-03-31 | $5 |
| 2025-12-31 | $-18 |
| 2025-09-30 | $9 |
| 2025-06-30 | $-17 |
| 2025-03-31 | $-54 |
| 2024-12-31 | $-34 |
| 2024-09-30 | $10 |
| 2024-06-30 | $7 |
| 2024-03-31 | $-3 |
| 2023-12-31 | $8 |
| 2023-09-30 | $5 |
| 2023-06-30 | $6 |
| 2023-03-31 | $3 |
| 2022-12-31 | $7 |
| 2022-09-30 | $10 |
| 2022-06-30 | $13 |
| 2022-03-31 | $10 |
| 2021-12-31 | $8 |
| 2021-09-30 | $6 |
| 2021-06-30 | $9 |
| 2021-03-31 | $5 |
| 2020-12-31 | $3 |
| 2020-09-30 | $4 |
| 2020-06-30 | $-1 |
| 2020-03-31 | $0 |
| 2019-12-31 | $6 |
| 2019-09-30 | $2 |
| 2019-06-30 | $4 |
| 2019-03-31 | $1 |
| 2018-12-31 | $1 |
| 2018-09-30 | $1 |
| 2018-06-30 | $2 |
| 2018-03-31 | $1 |
| 2017-12-31 | $0 |
| 2017-09-30 | $1 |
| 2017-06-30 | $-1 |
| 2017-03-31 | $-2 |
| 2016-12-31 | $0 |
| 2016-09-30 | $-2 |
| 2016-06-30 | $-2 |
| 2016-03-31 | $-8 |
| 2015-12-31 | $-1 |
| 2015-09-30 | $-2 |
| 2015-06-30 | $-2 |
| 2015-03-31 | $-2 |
| 2014-12-31 | $-3 |
| 2014-09-30 | $-3 |
| 2014-06-30 | $-2 |
| 2014-03-31 | $-1 |
| 2013-12-31 | $-1 |
| 2013-09-30 | $1 |
| 2013-06-30 | $0 |
| 2013-03-31 | $0 |
| 2012-12-31 | $-1 |
| 2012-09-30 | $0 |
| 2012-06-30 | $0 |
| 2012-03-31 | $0 |
| 2011-12-31 | $0 |
| 2011-09-30 | $0 |
| 2011-06-30 | $1 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical & Dental Supplies | $1.309B | $0.239B |
| Staar Surgical Company has evolved to become a developer, manufacturer and global distributor of products used by ophthalmologists and other eye care professionals to improve or correct vision in patients suffering from refractive conditions, cataracts and glaucoma. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| McKesson (MCK) | United States | $106.025B | 23.03 |
| Cardinal Health (CAH) | United States | $50.715B | 22.43 |
| Becton Dickinson (BDX) | United States | $43.913B | 11.10 |
| West Pharmaceutical Services (WST) | United States | $18.493B | 35.19 |
| Straumann Holding AG (SAUHY) | Switzerland | $16.902B | 0.00 |
| Cooper (COO) | United States | $13.894B | 16.52 |
| Align Technology (ALGN) | United States | $12.400B | 21.09 |
| Henry Schein (HSIC) | United States | $8.645B | 15.16 |
| Merit Medical Systems (MMSI) | United States | $4.072B | 19.84 |
| DENTSPLY SIRONA (XRAY) | United States | $2.339B | 7.36 |
| CONMED (CNMD) | United States | $1.107B | 7.97 |
| Pro-Dex (PDEX) | United States | $0.165B | 19.65 |
| Lifevantage (LFVN) | United States | $0.053B | 5.46 |
| Axe Compute (AGPU) | United States | $0.022B | 0.00 |